Product Code: RP-ID-10085975 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10085975
Market Overview:
Global Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital & Clinic, Homecare, Others) and Regional Forecasts 2019-2026
Global Lancets market is valued approximately USD 715.3 million in 2018 and is anticipated to grow with a growth rate of more than 12.5 % over the forecast period 2019-2026. Lancet is a medical implement used for capillary blood sampling. It is similar to scalpel, but it has a double edge blade or needle. These can make punctures to obtain small blood samples and they are generally disposable. Further, growing incidence of contagious and non-contagious diseases, increasing prevalence of diabetes, and rising inclination towards homecare and home diagnostics has led the adoption of Lancets across the forecast period. However, the risk associated with blood transfusion impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Lancets market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers, etc. and the growth in insulin users. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as growing healthcare industry, rising geriatric population in China and India, rapid economic growth, and rising awareness about diabetes treatment would create lucrative growth prospects for the Lancets market across Asia-Pacific region.
Major market player included in this report are:
Becton, Dickinson and Company (US)
Roche Diagnostics (Switzerland)
Ypsomed (Switzerland)
B. Braun Melsungen (Germany)
Terumo Corporation (Japan)
Own Mumford (UK)
HTL-STREFA S.A (Poland)
ARKRAY (Japan)
Sarstedt (Germany)
SteriLance Medical (Suzhou) (China)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Safety lancets
Push-Button Lancets
Pressure-Activated Lancets
Side-Buttoned Lancets
Personal Lancets
By Application:
Glucose Testing
Haemoglobin Testing
Coagulation Testing
Other Applications
By End-User:
Hospitals & Clinics
Home Care Settings
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Lancets Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Roche Diagnostics (Switzerland)
Ypsomed (Switzerland)
B. Braun Melsungen (Germany)
Terumo Corporation (Japan)
Own Mumford (UK)
HTL-STREFA S.A (Poland)
ARKRAY (Japan)
Sarstedt (Germany)
SteriLance Medical (Suzhou) (China)
Related Reports
Proof of Quality & Reliability
